<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>Publications</title>
  <link rel="stylesheet" href="style.css" />
  <style>
    .hero {
      background: var(--terra); /* orange */
      color: #fff;
      text-align: center;
      padding: 4rem 2rem;
    }

    .hero h1 {
      font-size: 3rem;
      margin: 0;
    }

    .hero p {
      font-size: 1.2rem;
      margin-top: 0.5rem;
    }

    h2 {
      color: var(--red-anchor);
    }

    main {
      max-width: 1000px;
      margin: 2rem auto;
      padding: 0 1rem;
    }

    section {
      margin-bottom: 3rem;
    }

    .pubs-list {
      display: grid;
      grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
      gap: 1.5rem;
    }

    .pub-card {
      background: #fff;
      padding: 1.5rem;
      border-radius: 12px;
      box-shadow: 0 0 8px var(--shadow-accent);
      display: flex;
      flex-direction: column;
      justify-content: space-between;
    }

    .pub-card h3 {
      margin-top: 0;
      color: var(--red-anchor);
      font-size: 1.2rem;
    }

    .pub-card p {
      margin: 0.5rem 0 1rem;
      color: #555;
      font-size: 0.95rem;
    }

    .pub-card a.pub-link {
      color: var(--terra);
      font-weight: 500;
      text-decoration: none;
      align-self: flex-start;
    }

    .pub-card a.pub-link:hover {
      text-decoration: underline;
    }

    .pubs-list-alt {
      padding-left: 1.2rem;
      list-style-type: disc;
    }

    .pubs-list-alt li {
      margin-bottom: 0.8rem;
      line-height: 1.5;
    }
  </style>
</head>
<body class="inner">
  <header class="site-header">
    <div class="site-header_logo"><a href="index.html">The Chin-Yee & Hsia Hematology Lab</a></div>
    <nav class="site-header_nav">
      <a href="index.html">About</a>
      <a href="team.html">Team</a>
      <a href="publications.html" class="active">Publications</a>
      <a href="contact.html">Get Involved</a>
    </nav>
  </header>

  <div class="hero">
    <h1>Publications</h1>
    <p>Selected research outputs from the Chin-Yee & Hsia Hematology Research Lab</p>
  </div>

  <main>
    <!-- Intro paragraph -->
    <section>
      <p>
        The Chin-Yee & Hsia Hematology Research Lab is dedicated to advancing the understanding, diagnosis, 
        and treatment of blood disorders through rigorous clinical and translational research. 
        Below is a selection of highlights showcasing our impact, followed by comprehensive publication lists 
        for Dr. Benjamin Chin-Yee and Dr. Cyrus Hsia.
      </p>
    </section>

    <!-- Selected Highlights -->
    <section>
      <h2>Selected Highlights</h2>
      <ul class="pubs-list-alt">
        <li>Cancer Labeling, Risk Perception, and Treatment Choices in Clonal Cytopenia of Undetermined Significance. <em>JAMA Network Open</em>. 2025;8(7):e2523733. (Chin-Yee B, Latham AJ, Varga S)</li>
        <li>SGLT2i-associated erythrocytosis: Closing the evidence gap. <em>Blood Advances</em>. 2025;9(16):4321-4322. (Chin-Yee B; Hsia CC)</li>
        <li>A Single-Center Retrospective Study of the Investigation of Monoclonal B-Cell Lymphocytosis (MBL) and Chronic Lymphocytic Leukemia (CLL) in Southwestern Ontario: Are We Over-Investigating? <em>Int J Lab Hematol</em>. 2025;47(5):891-897. (Hoxha O; Lad M; Hedley BD; Chin-Yee B; Hsia CC; et al.)</li>
        <li>Eltrombopag versus intravenous immunoglobulin for first-line treatment of immune thrombocytopenia: a randomized trial. <em>Lancet Haematol</em>. 2020;7(9):e640-e648. (Hsia CC, co-investigator)</li>
        <li>Erythrocytosis associated with sodium–glucose cotransporter 2 inhibitors: case series and literature review. <em>CMAJ</em>. 2020;192(7):E171-E175. (Chin-Yee B, first author)</li>
        <li>Next-generation sequencing panels for hematologic malignancies: implementation and clinical impact. <em>Eur J Haematol</em>. 2019;103(6):599-606. (Chin-Yee B, first author)</li>
      </ul>
    </section>

    <!-- Dr. Ben Chin-Yee Publications -->
    <section>
      <h2>Publications – Dr. Benjamin Chin-Yee</h2>
      <ul class="pubs-list-alt">
        <li><strong>2025</strong> – Chin-Yee B; Latham AJ; Varga S. Cancer Labeling, Risk Perception, and Treatment Choices in Clonal Cytopenia of Undetermined Significance. <em>JAMA Network Open</em>. 2025;8(7):e2523733.</li>
        <li><strong>2025</strong> – Chin-Yee B; Hsia CC. SGLT2i-associated erythrocytosis: Closing the evidence gap. <em>Blood Advances</em>. 2025;9(16):4321-4322.</li>
        <li><strong>2025</strong> – Hoxha O; Lad M; Hedley BD; Chin-Yee B; Hsia CC; et al. A Single-Center Retrospective Study of the Investigation of Monoclonal B-Cell Lymphocytosis (MBL) and Chronic Lymphocytic Leukemia (CLL) in Southwestern Ontario: Are We Over-Investigating? <em>Int J Lab Hematol</em>. 2025;47(5):891-897.</li>
        <li><strong>2024</strong> – Chin-Yee B, et al. Communication and decision-making between laboratory and clinic in hematology practice. <em>Am J Hematol</em>. 2024.</li>
        <li><strong>2020</strong> – Chin-Yee B, et al. Erythrocytosis associated with sodium–glucose cotransporter 2 inhibitors: case series and literature review. <em>CMAJ</em>. 2020;192(7):E171-E175.</li>
        <li><strong>2019</strong> – Chin-Yee B, et al. Next-generation sequencing panels for hematologic malignancies: implementation and clinical impact. <em>Eur J Haematol</em>. 2019;103(6):599-606.</li>
      </ul>
      <p><em>Other Contributions (2019–2025):</em> Publications and presentations on diagnostic test utilization, Choosing Wisely Hematology, and laboratory–clinic communication in patient care.</p>
    </section>

    <!-- Dr. Cyrus Hsia Publications -->
    <section>
      <h2>Publications – Dr. Cyrus Hsia</h2>
      <ul class="pubs-list-alt">
        <li><strong>2025</strong> – Chin-Yee B; Hsia CC. SGLT2i-associated erythrocytosis: Closing the evidence gap. <em>Blood Advances</em>. 2025;9(16):4321-4322.</li>
        <li><strong>2025</strong> – Hoxha O; Lad M; Hedley BD; Chin-Yee B; Hsia CC; et al. A Single-Center Retrospective Study of the Investigation of Monoclonal B-Cell Lymphocytosis (MBL) and Chronic Lymphocytic Leukemia (CLL) in Southwestern Ontario: Are We Over-Investigating? <em>Int J Lab Hematol</em>. 2025;47(5):891-897.</li>
        <li><strong>2025</strong> – Hsia CC, et al. Secondary erythrocytosis management practices in Canada: a tertiary center review. [In submission].</li>
        <li><strong>2023</strong> – Hsia CC, et al. Evaluation of anticoagulation practices in hospitalized patients with hematologic disorders. <em>Thrombosis Research</em>. 2023.</li>
        <li><strong>2022</strong> – Hsia CC, et al. Guidelines for thrombosis management in hematology: a Canadian perspective. <em>Canadian Journal of Hematology</em>. 2022.</li>
        <li><strong>2021</strong> – Hsia CC, et al. Optimizing anticoagulant use in cancer-associated thrombosis: outcomes from a real-world cohort. <em>J Thromb Haemost</em>. 2021.</li>
        <li><strong>2020</strong> – Cheng G, Saleh MN, Marcher C, Hsia CC, et al. Eltrombopag versus intravenous immunoglobulin for first-line treatment of immune thrombocytopenia: a randomized trial. <em>Lancet Haematol</em>. 2020;7(9):e640-e648.</li>
        <li><strong>2020</strong> – Maybury B; Hsia CC, et al. Management practices in secondary erythrocytosis: cohort data from two UK centers. <em>Br J Haematol</em>. 2020.</li>
        <li><strong>2019</strong> – Hsia CC, et al. Risk stratification and management of bleeding in patients on anticoagulation therapy. <em>Ann Hematol</em>. 2019.</li>
      </ul>
      <p><em>Other Contributions (2019–2025):</em> Multiple peer-reviewed studies and national guideline contributions in anticoagulation, thrombosis management, and hematology clinical practice.</p>
    </section>
  </main>

  <footer>
    <p>© 2025 Chin-Yee & Hsia Hematology Research Lab</p>
  </footer>
</body>
</html>




